Visiting/Using the site requires accepting our privacy policies - Click to accept

Precision Nanomedicine

The official journal of CLINAM

About the Journal: Precision Nanomedicine (PRNANO) is a peer-reviewed, not-for-profit, international society journal to promote all practical, rational, and progressive aspects of theory and practice of nanomedicine, from basic research through translational and clinical aspects including commercialization.

PRNANO provides an open access forum with reliable content and quick turnaround time.

We invite authors to submit both original, as well as replication studies. Discussions of negative results are also welcome if they move the field forward.  Papers are published continuously then organized into quarterly issues.

Please, note that HTML files are optimized for computer scans and pdf files for download and reading.

PRNANO is digitally distributed by a scientists-owned non-profit publisher: Andover House Inc, 138 River Rd, Andover, Massachusetts, 01810, USA.

 ISSN: 2639-9431 (online)

Nanoparticle-Encapsulated Doxorubicin Demonstrates Superior Tumor Cell Kill in Triple Negative Breast Cancer Subtypes Intrinsically Resistant to Doxorubicin
- Krausz AE, Adler BL, Makdisi J, Schairer D, Rosen J, Landriscina A, Navati M, Alfieri A, Friedman JM, Nosanchuk JD, Rodriguez-Gabin A, Ye KQ, McDaid HM, Friedman AJ.
Liposomal formulation of polyacrylate-peptide conjugate as a new vaccine candidate against cervical cancer
- Khongkow M, Liu TY, Bartlett S, Hussein WM, Nevagi R, Jia ZF, Monteiro MJ, Wells J, Ruktanonchai UR, Skwarczynski M, Toth I.
Specific Molecular Recognition as a Strategy to Delineate Tumor Margin Using Topically Applied Fluorescence Embedded Nanoparticles
- Barton S, Li B, Siuta M, Janve VA, Song J, Holt CM, Tomono T, Ukawa M, Kumagai H, Tobita E, Wilson K, Sakuma S, Pham W.
Download PDF Views: 262     Downloads: 101

Specific Molecular Recognition as a Strategy to Delineate Tumor Margin Using Topically Applied Fluorescence Embedded Nanoparticles

Research Article

Shawn Barton2, Bo Li2, Michael Siuta2, Vaibhav A Janve2, Jessica Song2, Clinton M. Holt2, Takumi Tomono1, Masami Ukawa1, Hironori Kumagai3, Etsuo Tobita3, Kevin Wilson2, Shinji Sakuma1* and Wellington Pham5, 7, 8, 9, 10, 12[1]

1Faculty of Pharmaceutical Sciences, Setsunan University, Hirakata, Osaka, Japan

2Vanderbilt University Institute of Imaging Science, Nashville, TN

3Life Science Materials Laboratory, ADEKA Corp., Tokyo, Japan

4Department of Radiology and Radiological Sciences, Vanderbilt University, Nashville, TN

5Department of Biomedical Engineering, Vanderbilt University, Nashville, TN

6Vanderbilt Ingram Cancer Center, Vanderbilt School of Medicine Nashville, TN

7Vanderbilt Brain Institute, Nashville, Vanderbilt University, TN

8Vanderbilt Institute of Chemical Biology, Nashville, TN

Submitted: July 18, 2018 Accepted: October 27, 2018